UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3

British journal of cancer, 1997-01, Vol.75 (2), p.161-168

1997

Volltextzugriff (PDF)

Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells : Participation of lysosomes

Blood, 1997-05, Vol.89 (10), p.3745-3754

1997

Volltextzugriff (PDF)

Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts

The Journal of biological chemistry, 1992-05, Vol.267 (15), p.10638-10644

1992

Volltextzugriff (PDF)

Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells

Biochemical pharmacology, 2001-06, Vol.61 (11), p.1393-1399

2001

Volltextzugriff (PDF)

Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells

Cancer research (Chicago, Ill.), 1994-11, Vol.54 (21), p.5607-5613

1994

Volltextzugriff (PDF)

Treatment of acute myeloid leukemia in the elderly with low‐dose cytarabine, hydroxyurea, and calcitriol

American journal of hematology, 1992-11, Vol.41 (3), p.178-183

1992

Volltextzugriff (PDF)

Abrogation of Mitochondrial Cytochrome c Release and Caspase-3 Activation in Acquired Multidrug Resistance

The Journal of biological chemistry, 1998-07, Vol.273 (27), p.16647-16650

1998

Volltextzugriff (PDF)

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

Drug design, development and therapy, 2015-01, Vol.9 (default), p.4479-4499

2015

Volltextzugriff (PDF)

Defective translocation of protein kinase C in multidrug-resistant HL-60 cells confers a reversible loss of phorbol ester-induced monocytic differentiation

The Journal of biological chemistry, 1993-06, Vol.268 (17), p.12267-12273

1993

Volltextzugriff (PDF)

Role of P-glycoprotein in dolastatin 10 resistance

Biochemical pharmacology, 1994-08, Vol.48 (3), p.609-612

1994

Volltextzugriff (PDF)

A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity

Blood, 1995-04, Vol.85 (7), p.1881-1887

1995

Volltextzugriff (PDF)

Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection : decreased anthracycline uptake precedes increased P-glycoprotein expression

Cancer research (Chicago, Ill.), 1990-12, Vol.50 (24), p.7895-7901

1990

Volltextzugriff (PDF)

Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP)

Biochemical pharmacology, 1996-11, Vol.52 (10), p.1569-1576

1996

Volltextzugriff (PDF)

Expression of the Multidrug Resistance Associated Protein and P-Glycoprotein in Doxorubicin-Selected Human Myeloid Leukemia Cells

Blood, 1994-11, Vol.84 (9), p.3113-3121

1994

Volltextzugriff (PDF)

Reversal of Multidrug Resistance with LY335979: Functional Analysis of P-glycoprotein-Mediated Transport Activity and Its Modulation In Vivo

Journal of clinical pharmacology, 2001-07, Vol.41 (S7), p.29S-38S

2001

Volltextzugriff (PDF)

An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines

Cancer research (Chicago, Ill.), 2004-06, Vol.64 (11), p.3761-3766

2004

Volltextzugriff (PDF)

PNEUMOCYSTIS CARINII PNEUMONIA AS A COMPLICATION OF DESFERRIOXAMINE THERAPY

British journal of haematology, 1988-11, Vol.70 (3), p.383-384

1988

Volltextzugriff (PDF)

Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines

Oncology research, 1997, Vol.9 (4), p.183

1997

Volltextzugriff (PDF)

A phase II trial of continuous infusion cisplatin and 5-fluorouracil with oral calcium leucovorin in colorectal carcinoma

American journal of clinical oncology, 1992-06, Vol.15 (3), p.239-241

1992

Volltextzugriff (PDF)

Differential Protection of Normal and Malignant Human Myeloid Progenitors (CFU-GM) From Ara-C Toxicity Using Cycloheximide

Blood, 1985-10, Vol.66 (4), p.830-834

1985

Volltextzugriff (PDF)

A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy

Clinical cancer research, 2004-05, Vol.10 (10), p.3265-3272

2004

Volltextzugriff (PDF)

A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma

American journal of clinical oncology, 1990-10, Vol.13 (5), p.455-458

1990

Volltextzugriff (PDF)

Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies

Clinical cancer research, 2004-11, Vol.10 (21), p.7220-7228

2004

Volltextzugriff (PDF)

Expression of c-fos precedes MDR3 in vincristine and adriamycin selected multidrug resistant murine erythroleukemia cells

Biochemical and biophysical research communications, 1996-09, Vol.226 (3), p.819

1996

Volltextzugriff (PDF)

A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Malignancies

Clinical cancer research, 2002-12, Vol.8 (12), p.3710-3717

2002

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(72)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(82)
Tagungsberichte
(1)

Sprache

Englisch
(82)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3

Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells : Participation of lysosomes

Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts

Modulation by LY335979 of P-glycoprotein function in multidrug-resistant cell lines and human natural killer cells

Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells

Treatment of acute myeloid leukemia in the elderly with low‐dose cytarabine, hydroxyurea, and calcitriol

Abrogation of Mitochondrial Cytochrome c Release and Caspase-3 Activation in Acquired Multidrug Resistance

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

Defective translocation of protein kinase C in multidrug-resistant HL-60 cells confers a reversible loss of phorbol ester-induced monocytic differentiation

Role of P-glycoprotein in dolastatin 10 resistance

A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity

Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection : decreased anthracycline uptake precedes increased P-glycoprotein expression

Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP)

Expression of the Multidrug Resistance Associated Protein and P-Glycoprotein in Doxorubicin-Selected Human Myeloid Leukemia Cells

Reversal of Multidrug Resistance with LY335979: Functional Analysis of P-glycoprotein-Mediated Transport Activity and Its Modulation In Vivo

An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines

PNEUMOCYSTIS CARINII PNEUMONIA AS A COMPLICATION OF DESFERRIOXAMINE THERAPY

Differential changes in genome structure and expression of the mdr gene family in multidrug-resistant murine erythroleukemia cell lines

A phase II trial of continuous infusion cisplatin and 5-fluorouracil with oral calcium leucovorin in colorectal carcinoma

Differential Protection of Normal and Malignant Human Myeloid Progenitors (CFU-GM) From Ara-C Toxicity Using Cycloheximide

A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy

A phase I-II trial of continuous-infusion cisplatin, continuous-infusion 5-fluorouracil, and VP-16 in colorectal carcinoma

Phase I Study of Docetaxel in Combination with the P-Glycoprotein Inhibitor, Zosuquidar, in Resistant Malignancies

Expression of c-fos precedes MDR3 in vincristine and adriamycin selected multidrug resistant murine erythroleukemia cells

A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar.3HCl Trihydrochloride (LY335979), Administered Orally in Combination with Doxorubicin in Patients with Advanced Malignancies

Suchergebnisse filtern